Skip to content
Monday, 10 August 2026 · NEW DELHI · 07:27
DIURNA

The day, on record.

  • World
  • India
  • Politics
  • Business
  • Technology
  • Sports
  • Health
  • Defence
  • Entertainment
  • Culture
  • Home
  • World
  • India
  • Politics
  • Business
  • Technology
  • Sports
  • Health
  • Defence
diurnanews.com
  • Home
  • World
  • India
  • Politics
  • Business
  • Technology
  • Sports
  • Health
  • Defence
  • Entertainment
  • Culture

Tag

pharma

1 article

Alkem Faces USFDA’s Toughest Warning at Daman Plant Despite EU Clearance
Health

Alkem Faces USFDA’s Toughest Warning at Daman Plant Despite EU Clearance

The USFDA classified Alkem Laboratories' Daman plant as Official Action Indicated, four months after the same site cleared European Union GMP standards.

By Diurna Editorial Team · 8 August 2026, 8:27 AM
Advertisement

Recent Posts

  • Alkem Faces USFDA’s Toughest Warning at Daman Plant Despite EU Clearance
  • India’s Police Modernisation Push: Why the Centre’s New Plan Matters
  • Bollywood Box Office 2026: 30 Films, Rs 2,671 Crore and One Dominant Hit
  • Nifty and Sensex Split After New Closing Auction Session: What Changed
  • FCRA Amendment Bill: How the New Asset Takeover Clause Could Reshape NGO Regulation

Recent Comments

No comments to show.

Archives

  • August 2026
  • July 2026

Categories

  • Business
  • Culture
  • Defence
  • Entertainment
  • Health
  • India
  • Politics
  • Sports
  • Technology
  • World
diurnanews.com

Sections

  • World
  • India
  • Politics
  • Business
  • Technology
  • Sports
  • Health
  • Defence
  • Entertainment
  • Culture

Legal

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Corrections Policy
  • Editorial Policy
  • Ownership & Funding
  • Grievance Redressal
  • Advertise With Us

Contact Us

Newsletter

No spam. Unsubscribe anytime.

© 2026 Diurna News Service . All rights reserved. Built on WordPress.

Privacy Policy Terms of Use Corrections Advertise About

We use cookies to improve your experience. By continuing to browse, you agree to our Privacy Policy and Terms of Use.